Increased carotid artery intima-media thickness is associated with a novel mutation of low-density lipoprotein receptor independently of major cardiovascular risk factors

Metabolism: Clinical and Experimental

Volumn 52, Issue 11, 2003, Pages 1433-1438

  Pauciullo, Paolo ^a,b,c   Giannino, Alessandro ^a,b,c   De Michele, Mario ^a,b,c   Gentile, Marco ^a,b,c   Liguori, Rosario ^a,b,c   Argiriou, Anagnostis ^a,b,c   Carlotto, Alessandra ^a,b,c   Faccenda, Fulvio ^a,b,c   Mancini, Mario ^a,b,c   Bond, M Gene ^a,b,c   De Simone, Vincenzo ^a,b,c   Rubba, Paolo ^a,b,c  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CHILD; CIGARETTE SMOKING; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; THICKNESS;

EID: 0344081920     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00255-5     Document Type: Article

References (21)

1. Scientific Steering Committee on behalf of the Simon Broome Register Group: Mortality in treated heterozygous familial hypercholesterolemia: Implications for clinical management. Atherosclerosis 142:105-112, 1999
2. Moorjani S, Roy M, Torres A, et al: Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolemia. Lancet 341:1303-1306, 1993
3. Graham CA, McLean E, Ward AJM, et al: Mutation screening and genotype: Phenotype correlation in familial hypercholesterolemia. Atherosclerosis 147:309-316, 1999
4. Gaudet D, Vohl MC, Couture P, et al: Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men. Atherosclerosis 143:153-161, 1999
5. Bertolini S, Cantafora A, Averna M, et al: Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol 20:E41-E52, 2000
6. Sijbrands EJ, Westendorp RG, Lombardi M P, et al: Additional risk factors influence excess mortality in heterozygous familial hypercholesterolemia. Atherosclerosis 149:421-425, 2000
7. Hopkins PN, Stephenson S, Wu LL, et al: Evaluation of coronary risk factors in patients with heterozygous Familial Hypercholesterolemia. Am J Cardiol 87:547-553, 2001
8. Descamps OS, Gibeau JP, Leysen X, et al: Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolemia. Eur J Clin Invest 31:958-965, 2001
9. Pauciullo P, Iannuzzi A, Sartorio R, et al: Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. Arterioscler Thromb 14:1075-1079, 1994
10. Rubba P, Mercuri M, Faccenda F, et al.: Premature carotid atherosclerosis: Does it occur in both familial hypercholesterolemia and homocystinuria? - Ultrasound assessment of arterial intima-media thickness and blood flow velocity. Stroke 25:943-950, 1994
11. Smith SC, Greenland P, Grundy SM: Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Circulation 101:111-116, 2000
12. Nowak J, Nilsson T, Sylvèn C, et al: Potential of carotid ultrasonography in the diagnosis of coronary artery disease. A comparison with exercise test and variance ECG. Stroke 29:439-446, 1998
13. Simon Broome Register Group: Risk of fatal coronary heart disease in familial hypercholesterolemia. BMJ 303:893-896, 1991
14. Liguori R, Bianco AM, Argiriou A, et al: LDL receptor cDNA sequence analysis in familial hypercholesterolemia patients: 5 novel mutations with high prevalence in families originating from Southern Italy. Hum Mutat 17:433-437, 2001
15. Tonstad S, Joakimsen O, Bugge-Stensland E, et al: Carotid intima-media thickness and plaque in patients with familial hypercholesterolemia mutations and control subjects. Eur J Clin Invest 28:971-979, 1998
16. Zanchetti A, Crepaldi G, Bond MG, et al: Systolic and pulse blood pressures (but not diastolic blood pressure) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolemic hypertensive patients of the Plaque. Hypertension Lipid Lowering Italian Study. J Hypertens 19:79-88, 2001
17. Tang R, Hennig M, Thomasson B, et al: Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: The European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 18:197-201, 2000
18. O'Leary D, Polak JF, Kronmal RA, et al: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340:14-22, 1999
19. Mercuri M, Bond MG, Sirtori CR, et al: Pravastatin reduces intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: The Carotid Italian Ultrasound Study. Am J Med 101:627-634, 1996
20. Furberg CD, Adams HP, Applegate WB, et al: Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 90:1679-1687, 1994
21. Boizel R, Benhamou PY, Lardy B, et al: Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal cholesterol levels. Diabetes Care 23:1679-1685, 2000